Top 10 Freeze Vaccine For Rabies Prophylaxis Manufacturers

July 22, 2024

The freeze vaccine for rabies prophylaxis is a crucial product in preventing the deadly virus in humans and animals. With increasing awareness about rabies, the demand for this vaccine is rising in the consumer market. It is essential for pet owners, veterinarians, and individuals at risk of exposure to rabies. The convenience of a freeze vaccine makes it a popular choice for those seeking protection against this deadly disease.

GlaxoSmithKline
China National Pharmaceutical Group (Sinopharm)
Novartis
Changchun Zhuoyi Biological Co., Ltd
Pfizer

GlaxoSmithKline

Establishment time : 2000

website : www.gsk.com

Main Product : Pharmaceuticals, vaccines, consumer healthcare products

Company Profile

GlaxoSmithKline is a leading healthcare company that focuses on research, development, and manufacturing of innovative pharmaceuticals, vaccines, and consumer healthcare products. With a global presence and a diverse product portfolio, GSK is dedicated to improving the quality of human life through its healthcare solutions.

China National Pharmaceutical Group (Sinopharm)

Establishment time : 1998

website : http://www.sinopharm.com/

Main Product : Pharmaceuticals, vaccines, medical devices

Company Profile

China National Pharmaceutical Group (Sinopharm) is a state-owned enterprise that specializes in the research, development, production, and distribution of pharmaceuticals, vaccines, and medical devices. With a focus on innovation and quality, Sinopharm has become a leading player in the global healthcare industry.

Novartis

Establishment time : Novartis was established on February 29, 1996.

website : www.novartis.com

Main Product : pharmaceuticals, generics, eye care, and vaccines.

Company Profile

Novartis is a multinational pharmaceutical company known for its innovative medicines and commitment to improving global health.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Pfizer

Establishment time : Pfizer is a leading pharmaceutical company with a long history of innovation and research.

website :

Main Product : Pfizer's portfolio includes a wide range of products for various medical conditions, from cardiovascular diseases to cancer.

Company Profile

As a pioneer in the field of pharmaceuticals, Pfizer remains at the forefront of medical innovation and research.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326